Informed Consent at Banner Health
Participation in any Banner Health research study is voluntary.
For every study in which a patient participates, he or she receives a document titled "Consent to Participate in a Clinical Research Study" that explains the study in straightforward language. A research team member discusses the study with the patient and answers any questions.
Patients are encouraged to discuss the study with family and friends, and they are never hurried into making decisions about whether to participate. Patients are asked to sign a consent document only after it is clear that they understand the nature of the study and agree to the commitment.
By virtue of conducting studies with patients afflicted with Alzheimer's disease and other dementias, those who do not have the capacity to consent on their own behalf may be enrolled by a caregiver or other legally authorized representative with assent from the patient. Banner Alzheimer's Institute (BAI) will, to the greatest extent possible, confirm that it is in fact the patient's desire to participate and that the individual understands the study process and objectives. However, given the nature of Alzheimer's disease, it is critical that the caregiver understand the requirements and be willing to assist in fulfilling the patient's study responsibilities.
Participants have the right to change their mind about whether to participate at any time during the study. They may withdraw from the study completely, or they may refuse particular tests or treatments. In some cases, however, such refusal may make the patient ineligible to continue the study.